SR
Sharda Rani
About Sharda Rani
Data last updated:
Sharda Rani is a Director at Esproute Neutrika Private Limited (since 2021) and Director at Gynapss Pharmaceuticals Priavte Limited (since 2021). The companies operate in Chemicals and Trading. Earlier, Sharda Rani was an Additional Director at Esproute Remedies Private Limited (2016–2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Esproute Neutrika Private Limited U24117UP2021PTC147126 | Director | 10 Jun 2021 | 2021 | Active | |
| Gynapss Pharmaceuticals Priavte Limited U24230UP2021PTC147138 | Director | 10 Jun 2021 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Esproute Remedies Private Limited U85191UP2016PTC075676 | Additional Director | 01 Mar 2016 | 2016 | ₹19.1 Lakh (FY 2017) | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sharda Rani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Brijesh Kumar Vishwakarma | 09199255 | Esproute Neutrika Private Limited | Director |
| Aarti Devi | 09199615 | Gynapss Pharmaceuticals Priavte Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sharda Rani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sharda Rani
Sharda Rani currently holds 2 directorships: Esproute Neutrika Private Limited (Director, since 10 Jun 2021); Gynapss Pharmaceuticals Priavte Limited (Director, since 10 Jun 2021).
Sharda Rani was first appointed on 01 Mar 2016 as Additional Director at Esproute Remedies Private Limited. The most recent appointment on record is 10 Jun 2021 at Gynapss Pharmaceuticals Priavte Limited.
Sharda Rani held 1 earlier board appointment: Esproute Remedies Private Limited (Additional Director, 01 Mar 2016 to 04 Jun 2021).
The current boards of Sharda Rani's companies include Brijesh Kumar Vishwakarma (Esproute Neutrika Private Limited), Aarti Devi (Gynapss Pharmaceuticals Priavte Limited).